Lembos Pharmaceuticals LLP

Lembos Pharmaceuticals LLP - pharma in New, Delhi, India. Directors, charges & compliance details.
LLPIN AAF-2347 Incorporated 28 November 2015 ROC Delhi HQ New, Delhi, India
Active Limited Liability Partnership pharma
Data last updated
Contribution obligation
₹1.53 Lakh
As per LLP agreement
LLP age
11 yrs
Est. 2015
Designated partners
3
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2023
Balance sheet date
LLP status
Active
MCA master data
Registrar
Delhi
ROC office
Incorporated
28 Nov 2015
Date of incorporation

About Lembos Pharmaceuticals LLP

Data last updated:

Lembos Pharmaceuticals LLP is a limited liability partnership (LLP) based in New, Delhi, India. It operates in the pharmaceutical products segment of the pharmaceuticals sector. It was incorporated on 28 November 2015 and has been in existence for over 11 years.

The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAF-2347. Its GSTIN is 07AAGFL0705M1ZC (Delhi).

The LLP has a total obligation of contribution of ₹1.53 Lakh. It is led by designated partners including Ajay Prem Juneja and Dewashish Pathak.

Its latest statement of accounts is for the year ended 31 March 2023. The registered office is at H. No. – 508/6 Kh No – 1529 GF Blk – Z Basai Darapur Near Ramesh Nagar Metro Station, New, Delhi, India – 110027.

Company Details of Lembos Pharmaceuticals LLP
LLPIN AAF-2347
Incorporation Date 28 November 2015
Total Obligation of Contribution ₹1.53 Lakh
ROC Delhi
Company Status Active
Date of Last AGM 31 March 2023
Date of Balance Sheet 31 March 2023
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    H. No. – 508/6 Kh No – 1529 GF Blk – Z Basai Darapur Near Ramesh Nagar Metro Station, New, Delhi, India – 110027
  • Industry
    Pharma, Pharmaceutical Products
Comprehensive company report
Lembos Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Lembos Pharmaceuticals LLP report

Financials, compliance, directors, charges, ownership and filings for Lembos Pharmaceuticals LLP in one report.

Financials from FY 2016 Directors & ownership Charges & compliance

Designated Partners of Lembos Pharmaceuticals LLP

Lembos Pharmaceuticals has 3 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Ajay Prem JunejaDesignated Partner28 Nov 201510 Years 10 MonthsCurrent
Dewashish PathakDesignated Partner28 Nov 201510 Years 10 MonthsCurrent
Dilip KumarDesignated Partner28 Nov 201510 Years 10 MonthsCurrent

Financials of Lembos Pharmaceuticals LLP FY 2023 filings available

Financial Statement Summary of Lembos Pharmaceuticals LLP

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Income and Expenditure
Turnover••••••••••••••••••••
Other Income••••••••••••••••••••
Total Income••••••••••••••••••••
Purchases and Direct Costs••••••••••••••••••••
Personnel Expenses••••••••••••••••••••
Administrative Expenses••••••••••••••••••••
Interest••••••••••••••••••••
Depreciation••••••••••••••••••••
Total Expenses••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax••••••••••••••••••••
Profit After Tax••••••••••••••••••••
Profit Transferred to Partners••••••••••••••••••••
Assets and Liabilities
Partners' Contribution••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Secured Loans••••••••••••••••••••
Unsecured Loans••••••••••••••••••••
Trade Payables••••••••••••••••••••
Other Liabilities and Provisions••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Loans and Advances••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Lembos Pharmaceuticals LLP

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
Net Profit Margin••••••••••••••••••••
Return on Partners' Funds••••••••••••••••••••
Return on Assets••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Debt to Partners' Funds••••••••••••••••••••
Interest Coverage••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Turnover Growth••••••••••••••••••••
Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Lembos Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2016

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Lembos Pharmaceuticals LLP

Lembos Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Lembos Pharmaceuticals LLP

Employment history and EPFO contributions of people linked to Lembos Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Lembos Pharmaceuticals LLP

Lembos Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAGFL0705M1ZCDelhiActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Lembos Pharmaceuticals LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Lembos Pharmaceuticals LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Lembos Pharmaceuticals LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Lembos Pharmaceuticals LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Lembos Pharmaceuticals LLP

Activity
31 Mar 2023
Lembos Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records.
Activity
31 Mar 2023
Lembos Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi Ii.
Directors
28 Nov 2015
Ajay Prem Juneja was appointed as a Designated Partner on 28 Nov 2015 & has been associated with this company since 10 years 10 months.
Directors
28 Nov 2015
Dewashish Pathak was appointed as a Designated Partner on 28 Nov 2015 & has been associated with this company since 10 years 10 months.
Directors
28 Nov 2015
Dilip Kumar was appointed as a Designated Partner on 28 Nov 2015 & has been associated with this company since 10 years 10 months.
Activity
28 Nov 2015
Lembos Pharmaceuticals Llp was registered on 28 Nov 2015 with Roc Delhi Ii & aged 10 years 10 months as per MCA records.

Frequently Asked Questions about Lembos Pharmaceuticals LLP

Lembos Pharmaceuticals is an active limited liability partnership based in New, Delhi, India. The LLP works in pharmaceutical products, within the pharma industry. It was incorporated on 28 November 2015 (11+ years old) and is registered under LLPIN AAF-2347.

Lembos Pharmaceuticals has 3 current designated partners:

The GSTIN of Lembos Pharmaceuticals is 07AAGFL0705M1ZC, registered in Delhi.

The LLPIN (Limited Liability Partnership Identification Number) of Lembos Pharmaceuticals is AAF-2347. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Lembos Pharmaceuticals was incorporated on 28 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.

The registered office of Lembos Pharmaceuticals is at H. No. – 5086 Kh No – 1529 GF Blk – Z Basai Darapur Near Ramesh Nagar Metro Station, New, Delhi, India – 110027.

The total obligation of contribution is ₹1.53 Lakh.

Lembos Pharmaceuticals operates in the pharma industry, in the pharmaceutical products segment.

Lembos Pharmaceuticals can be reached at its registered office: H. No. – 5086 Kh No – 1529 GF Blk – Z Basai Darapur Near Ramesh Nagar Metro Station, New, Delhi, India – 110027.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available